URL | Priority | Change frequency | Last modified (GMT) |
---|---|---|---|
https://beyondspringpharma.com/beyondspring-presents-updated-efficacy-results-from-a-phase-2-iit-study-of-triple-io-combo-of-pembrolizumab-plus-plinabulin-docetaxel-in-metastatic-nsclc-after-progressing-on-prior-immune-checkpoint-i/ | 20% | Monthly | 2024-11-11 19:34 |